Researchers discover key biochemical mechanism in Huntington's disease development







Researchers from the University of Oxford have identified a key biochemical mechanism relevant to the development of Huntington's Disease. This discovery opens up the possibility of studying the disease before its clinical onset and eventually stopping its progression.

The study, published in Nature Metabolism, has shown for the first time the biochemical change responsible for the development of Huntington's disease, and how blocking this change stopped disease progression.

Huntington's disease is an inherited condition that stops parts of the brain from working properly, leading to mental and physical decline that slowly worsens over time. The symptoms usually begin to appear after the age of 30 years and are fatal, but this can be after a period of up to 20 years, during which they worsen.

The study explores how an early change described in the brain of HD patients in the early 1980s could lead to Huntington's disease onset. The researchers identified that problems with specific neurons in the brain, called indirect pathway spiny projection neurons (iSPNs), which are the initially affected cells in HD, may trigger an imbalance in dopamine levels upon missing an important signalling derived from the activation of the neurotrophin receptor TrkB. This imbalance is linked to early symptoms of the disease, such as abnormal, involuntary movements.

First the researchers looked at mice that lacked normal function in these iSPNs due to disrupted TrkB neurotrophin signalling and noticed that they showed increased levels of dopamine in the brain, leading to hyperactivity. This change occurred before noticeable symptoms appeared, suggesting that these early alterations may contribute significantly to HD progression.

The researchers also found that a protein called GSTO2, an enzyme that is part of the glutathione metabolism, plays an important role in regulating dopamine levels. By selectively reducing the activity of this protein in mice, the researchers were able to prevent dopamine and energy metabolism dysfunction, arresting the onset of motor symptoms in mice.

Importantly, this enzyme shows similar dysregulation in a rat model of HD and some rare brains of asymptomatic HD patients, confirming its putative relevance to the development of the disorder.

The study's lead author, Liliana Minichiello, Professor of Cellular and Molecular Neuroscience at Oxford's Department of Pharmacology, said: 'The big problem with Huntington's disease is that by the time that symptoms develop much of the damage has already been done, and therefore, it is fundamental that we understand the changes that occur before the disorder develops if we are to develop effective therapeutics.'

'This research marks the first time that we have been able to identify a specific chemical change that is unique to the development of Huntington's disease, which opens the possibility of developing new tests to study the early changes of the disease before irreversible damage occurs.

'Understanding these early changes provides crucial insights into how Huntington's Disease develops, and this knowledge could help develop preventive therapies to maintain dopamine balance and delay or halt disease progression.'


Website: Global Innovation Technologist Awards

#Biochemistry #Sciencefather #Research award #MolecularBiology, #Proteomics, #Metabolomics, #EnzymeKinetics, #CellBiology, #BiochemicalResearch, #ProteinStructure, #Genomics, #BiochemicalEngineering, #StructuralBiology, #SystemsBiology, #BiochemicalPathways, #ChemicalBiology, #Bioinformatics, #Pharmacology, #DrugDesign, #BiochemicalAnalysis, #MetabolicPathways #Professor, #Lecturer, #Scientist, #Scholar, #Researcher, #Analyst, #Engineer, #Technician, #Coordinator, #Specialist, #Writer, #Assistant, #Associate, #Biologist, #Chemist, #Physicist, #Statistician, #DataScientist

Visit Our Website : innovationtechnologist.com

Get Connected Here:
==================
Social Media Link

Comments

Post a Comment

Popular posts from this blog

Biochemists create protocells to explore how lipids may have led to first cell membranes

Image
A team of biochemists at the University of California, San Diego, working with a group of biochemical engineers from the University of California, Los Angeles, has found that the development of short lipids might have led to the development of the first cell membranes on early Earth. In their study published in the journal Nature Chemistry , the group combined cysteine with chemical relatives of fatty acids to form lipids with two tails, finding clues about the origins of life on Earth. The research team reasoned that for cells to get their start on early Earth, some form of cell boundary must have formed first to protect cell contents from the environment. Noting that modern cell membranes are all made of lipids, the researchers wondered if the first cell membranes might have been made of lipids as well—and if that was the case, how they might have developed from simple molecules. They also noted that modern cell membranes are complex and generally long chained. Suspecting that earl...
Read more

From chaos to order: Proteins can re-structure themselves to create important substances

Image
The protein 'MIPS' changes its internal structure when it becomes active. Its disordered active centre becomes a defined structure with special functions. The protein plays a key role in the production of inositol, which is also known as vitamin B8, and fulfils important tasks in the body. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the National Hellenic Research Centre in Greece have succeeded for the first time in observing the protein as it re-structures. As the team reports in the scientific journal 'Proceedings of the National Academy of Sciences' (PNAS) this process appears to occur in many similar proteins. Proteins control all vital processes in every organism, for example growth and metabolism. A basic principle of protein research is that the structure of each protein determines its function. If the structure is impaired at just one specific point, the protein can no longer fulfil its function. In the human body, this can lead, for exam...
Read more

Amie Boal named Nicholas and Gelsa Pelick Family Chair in Science

Image
UNIVERSITY PARK, Pa. — Amie Boal, professor of chemistry and of biochemistry and molecular biology, has been named the Nicholas and Gelsa Pelick Family Chair in Science . The purpose of the endowed faculty chair is to provide an outstanding biochemist in the Department of Chemistry or the Department of Biochemistry and Molecular Biology with the resources needed to continue and further their contributions to research , teaching and public service. “I am extremely pleased that we can recognize Amie’s accomplishments and many contributions to Penn State with this well-deserved appointment,” said Mary Beth Williams, acting dean of the Eberly College of Science, James and Alvina Balog Faculty Fellow in Science , and professor of chemistry . “Amie was chosen for her exceptional research , teaching and service to the Department of Chemistry and the Eberly College of Science. She is an integral part of the college’s commitment to excellence and I’m certain that will continue with this new ap...
Read more